191 related articles for article (PubMed ID: 34975712)
1. The Correlation Among the Immunoglobulin G Synthesis Rate, IgG Index and Albumin Quotient in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Retrospective Case-Control Study.
Tu Y; Gong X; Zhang Y; Peng J; Zhuo W; Yu X
Front Neurol; 2021; 12():746186. PubMed ID: 34975712
[No Abstract] [Full Text] [Related]
2. Differences in Thyroid Function and Autoantibodies in the Development of Guillain-Barré Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Tu Y; Gong X; Zeng G; Zhuo W; Li Z; Yu X
Front Neurol; 2020; 11():1018. PubMed ID: 33013669
[No Abstract] [Full Text] [Related]
3. Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies.
Ruiz M; Puthenparampil M; Campagnolo M; Castellani F; Salvalaggio A; Ruggero S; Toffanin E; Cacciavillani M; Gallo P; Franciotta D; Briani C
J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):969-974. PubMed ID: 33850000
[TBL] [Abstract][Full Text] [Related]
4. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid analysis in Guillain-Barré syndrome: value of albumin quotients.
Rath J; Zulehner G; Schober B; Grisold A; Krenn M; Cetin H; Zimprich F
J Neurol; 2021 Sep; 268(9):3294-3300. PubMed ID: 33651153
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
[TBL] [Abstract][Full Text] [Related]
7. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
8. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.
Breville G; Lascano AM; Roux-Lombard P; Vuilleumier N; Lalive PH
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34140310
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
Blum S; McCombe PA
J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
[TBL] [Abstract][Full Text] [Related]
11. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
12. Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barré syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy?
Weller M; Stevens A; Sommer N; Wiethölter H
Eur Arch Psychiatry Clin Neurosci; 1992; 242(2-3):122-6. PubMed ID: 1486101
[TBL] [Abstract][Full Text] [Related]
13. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
14. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
16. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Capodivento G; De Michelis C; Carpo M; Fancellu R; Schirinzi E; Severi D; Visigalli D; Franciotta D; Manganelli F; Siciliano G; Beronio A; Capello E; Lanteri P; Nobile-Orazio E; Schenone A; Benedetti L; Nobbio L
J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):303-310. PubMed ID: 33093191
[TBL] [Abstract][Full Text] [Related]
17. Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barré syndrome.
Matà S; Galli E; Amantini A; Pinto F; Sorbi S; Lolli F
Eur J Neurol; 2006 Feb; 13(2):153-60. PubMed ID: 16490046
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
Inglis HR; Csurhes PA; McCombe PA
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):419-22. PubMed ID: 17158557
[TBL] [Abstract][Full Text] [Related]
20. Increased Cerebrospinal Fluid Adenosine 5'-Triphosphate Levels in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.
Nukui T; Niimi H; Hayashi T; Dougu N; Yamamoto M; Shibuya R; Matsuda N; Tanaka R; Hirosawa H; Furuta R; Mitsui T; Maesaka H; Takasawa S; Kitajima I; Nakatsuji Y
Neurol Res Int; 2024; 2024():7229216. PubMed ID: 38887668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]